Marker continues to enroll patients and activate clinical sites in Phase 2 AML trial following completion of safety lead-in
Company's new in-house cGMP manufacturing facility in Houston is fully operational
PR Newswire
HOUSTON, Aug. 10, 2021
PR Newswire
HOUSTON, Aug. 10, 2021
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey